Pharmafile Logo
Pharmafocus logo
Advanced Search
WHO flag

Novartis and Biogen launch drug access programmes in developing countries

October 15, 2015
Manufacturing and Production, Sales and Marketing Biogen, Novartis, access, aid, corporate social responsibility, csr, humanitarian aid

Novartis and Biogen have begun new campaigns aimed at increasing access to medicines in developing countries.  The Swiss firm has …

News
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015
Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …

News
Hilary Clinton

Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters

October 14, 2015
Drug pricing, Hilary Clinton, US, pricing reform

Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …

News
vrvb9xyi

Turing faces antitrust probe over Daraprim price hike

October 14, 2015
Sales and Marketing Daraprim, Turing Pharmaceuticals, turing

Turing Pharmaceuticals, the drug company that increased the price of the generic drug Daraprim 50-fold overnight, is facing an antitrust …

News
ebola_virus

Johnson & Johnson begins Ebola vaccine trial in Sierra Leone

October 14, 2015
Research and Development Ebola vaccine, Johnson & Johnson

Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …

News
AstraZeneca plaque

AstraZeneca accused of tax avoidance in Dutch scheme

October 14, 2015
AstraZeneca, finance, tax, tax avoidance

AstraZeneca is the latest international firm to be accused of corporation tax avoidance, after an investigation claimed the firm is …

News
lars-rebien-soerensen

Novo chief executive ranked ‘world’s best’

October 14, 2015
Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk

Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …

Appointment
boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015
Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …

News
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015
Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …

Appointment

Merck rebrands as ‘science and technology’ company

October 14, 2015
Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

News
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015
Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …

News
dna

Featured Market Report: Gene Therapies Outlook

October 13, 2015
Manufacturing and Production, Research and Development

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …

Feature
cinryze_logo

Shire’s Cinryze gets FDA fast track designation

October 13, 2015
Research and Development AMR, FDA, Shire

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …

News
medimmune_2

AstraZeneca’s MedImmune joins Human Vaccines Project

October 13, 2015
Research and Development Human Vaccines Project, MedImmune

MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …

News
gamidi_cell_logo

Novartis invests further $15m into Gamida Cell

October 13, 2015
Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …

News
s_oschmann_2015

Stefan Oschmann promoted to top job at Merck KGaA

October 13, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …

Appointment
oma_nice

NICE launches new service to speed NHS adoption of health technologies

October 13, 2015
Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access

NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …

News
manufacturing China

Contact manufacturing ‘is changing the industry’, report finds

October 13, 2015
Manufacturing and Production CMO, contract manufacturing, manufacturing, pharma, production

The global market for pharma and biopharma contract manufacturing is expected to reach more than €332.7 billion by 2018, according …

News
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015
Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …

Feature

AstraZeneca halts lung cancer trials amidst safety concerns

October 13, 2015
Manufacturing and Production AZD9291, AstraZeneca, MEDI4736, NSCLC, drug safety, durvalumab, interstitial lung disease, lung cancer, non-small cell lung cancer

AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026